Anxiety disorders are a family of mental disorders characterized by excessive and persistent fear, anxiety, worry and avoidance behaviors. They include panic disorder, agoraphobia, specific phobia, social anxiety disorder, generalized anxiety disorder and obsessive compulsive disorder. Anxiety disorders are highly prevalent, affecting around 1 in 4 people at some point in their lives. They are more common in women and often have an early age of onset. Biological, genetic, psychological and environmental factors all contribute to the development of anxiety disorders.
antipsychotics history, managment of psychosis,side effect of antipsychotics, mechanism of antipsychotics, atypical antipsychotics,2nd generation antipsychotics.
Psychosis is an abnormal condition of the mind that involves a “loss of contact with reality”. People experiencing psychosis may exhibit personality changes and thought disorder. Depending on its severity, this may be accompanied by unusual or bizarre behavior, as well as difficulty with social interaction and impairment in carrying out daily life activities.
Thanks to:
God, Parents and Teachers
and Mrs. Tahira Khan [Department of Pharmacology]
antipsychotics history, managment of psychosis,side effect of antipsychotics, mechanism of antipsychotics, atypical antipsychotics,2nd generation antipsychotics.
Psychosis is an abnormal condition of the mind that involves a “loss of contact with reality”. People experiencing psychosis may exhibit personality changes and thought disorder. Depending on its severity, this may be accompanied by unusual or bizarre behavior, as well as difficulty with social interaction and impairment in carrying out daily life activities.
Thanks to:
God, Parents and Teachers
and Mrs. Tahira Khan [Department of Pharmacology]
This short presentation demonstrates important adverse effects of common anti-psychotic medications in clinical practice and how to effectively manage the adverse events.
Depressive Disorders: An Overview of Full Spectrum. Dr. Ashok Kumar Batham.DrAshok Batham
Medical specialists outside the area of psychiatry and those who practice family medicine generally get fragmented information about mental depression. Therefore, an endeavour has been made to provide a complete overview of various depressive disorders, such as, Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD) or Dysthymia, Disruptive Mood Dysregulation Disorder (DMDD), Premenstrual Dysphoric Disorder (PMDD), Substance/Medication Induced Depressive Disorder, Depressive Disorder Due to Another Medical Condition, and other depressive disorders. DSM-5 diagnostic criteria of each of these disorders are given along with vignettes of diagnosis and treatment of the same are presented. Hopefully, this slide share will help non-psychiatrists to understand the complete spectrum of depressive disorders.
Psychoeducation is an important element of psychiatric treatment. It has a significant role in
promoting mental health, preventing mental illness, increasing mental health awareness, creating opportunities
and improving the quality of life of the patient, caregivers and the community. To achieve these goals,
psychoeducation programmes seek to provide families with the information they need about mental illness
and the coping skills that will help them to deal with their loved one's psychiatric disorder. In a nutshell
Psychoeducation’s goal is to offer education and therapeutic strategies to improve the quality of life for the
family while decreasing the possibility of relapse for the patient (Solomon, 1996).
This short presentation demonstrates important adverse effects of common anti-psychotic medications in clinical practice and how to effectively manage the adverse events.
Depressive Disorders: An Overview of Full Spectrum. Dr. Ashok Kumar Batham.DrAshok Batham
Medical specialists outside the area of psychiatry and those who practice family medicine generally get fragmented information about mental depression. Therefore, an endeavour has been made to provide a complete overview of various depressive disorders, such as, Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD) or Dysthymia, Disruptive Mood Dysregulation Disorder (DMDD), Premenstrual Dysphoric Disorder (PMDD), Substance/Medication Induced Depressive Disorder, Depressive Disorder Due to Another Medical Condition, and other depressive disorders. DSM-5 diagnostic criteria of each of these disorders are given along with vignettes of diagnosis and treatment of the same are presented. Hopefully, this slide share will help non-psychiatrists to understand the complete spectrum of depressive disorders.
Psychoeducation is an important element of psychiatric treatment. It has a significant role in
promoting mental health, preventing mental illness, increasing mental health awareness, creating opportunities
and improving the quality of life of the patient, caregivers and the community. To achieve these goals,
psychoeducation programmes seek to provide families with the information they need about mental illness
and the coping skills that will help them to deal with their loved one's psychiatric disorder. In a nutshell
Psychoeducation’s goal is to offer education and therapeutic strategies to improve the quality of life for the
family while decreasing the possibility of relapse for the patient (Solomon, 1996).
It is an emotional state, unpleasant in nature, associated with uneasiness, discomfort and concern or fear about some defined or undefined future threat. Some degree of anxiety is a part of normal life. Treatment is needed when it is disproportionate to the situation and excessive.
The paper deals with panic disorder and its various underlying causes in the simplest form. It also explains the various signs and symptoms and its mechanism. The paper concludes with explaining various treatments and the diagnostic procedure.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Studia Poinsotiana
I Introduction
II Subalternation and Theology
III Theology and Dogmatic Declarations
IV The Mixed Principles of Theology
V Virtual Revelation: The Unity of Theology
VI Theology as a Natural Science
VII Theology’s Certitude
VIII Conclusion
Notes
Bibliography
All the contents are fully attributable to the author, Doctor Victor Salas. Should you wish to get this text republished, get in touch with the author or the editorial committee of the Studia Poinsotiana. Insofar as possible, we will be happy to broker your contact.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
2. DEFINITION
• Anxiety is a psychological and physiological state
characterized by cognitive, somatic, emotional
and behavioral components
• A response to a threat that’s unknown, internal,
vague or conflictual
• Fear is a response to a known, external, definite
or non conflictual threat
• Anxiety disorders are a family of related but
distinct mental disorders xtized by excessive and
persistent fear, anxiety, worry and/or avoidance
behavior
3. CLASSIFICATION (DSM-IV-TR)
1. Panic disorder with agoraphobia
2. Panic disorder without agoraphobia
3. Agoraphobia without panic disorder
4. Specific phobia
5. Social phobia
6. Obsessive-compulsive disorder (OCD)
7. Post-traumatic stress disorder (PTSD)
8. Acute stress disorder
9. Generalized anxiety disorder
4. EPIDEMIOLOGY
• Among the most prevalent mental disorders in the general public
• F:M 2:1
• Significant morbidity and often are chronic and resistant to treatment
• The National Comorbidity Study report
one of four persons met the diagnostic criteria for at least one anxiety
disorder
12-month prevalence rate of 17.7 percent.
• Women with 30.5% lifetime prevalence and men 19.2%
• Prevalence of anxiety disorders decreases with higher socioeconomic
status
5. Etiology
Theories that try to explain anxiety disorders
I. Psychological theories
II. Genetic theory
III.Biochemical theory
IV.Neuroanatomial
6. I. Psychological theories
A. Psychoanalytic theory & psychodynamic theory
According to Freud, anxiety is a result of psychic conflict
between unconscious sexual or aggressive wishes by ID and
corresponding threats from the superego or external reality.
In response to this signal, the ego mobilized defense
mechanisms to prevent unacceptable thoughts and feelings
from emerging into conscious awareness
Psychodynamic theory
Superego anxiety is related to guilt feelings about not living up
to internalized standards of moral behavior derived from the
parents.
7. B) Behavioral Theory
Anxiety is a conditioned response to a specific
environmental stimulus explained by a model of classic
conditioning
A girl raised by an abusive father may become anxious
as soon as she sees the abusive father and may develop
to distrust men
A child may also develop anxiety response by imitating
the anxiety in the environment, as in anxious parents
8. C) Existential Theory
This provides a model for generalized anxiety
where no specific identifiable stimulus exist for
a chronically anxious feeling
persons experience feelings of living in a
purposeless universe.
Anxiety is their response to the perceived void
in existence and meaning
9. II. Genetic Theory
Heredity recognized as a predisposing factor in the
development of anxiety disorders.
Almost half of all patients with panic disorder have at
least one affected relative.
One report attributed about 4% of the intrinsic variability
of anxiety within the general population to a
polymorphic variant of the gene for the serotonin
transporter, which is the site of action of many
serotonergic drugs
Persons with the variant produce less transporter and
have higher levels of anxiety
10. III. Biochemical Theories
Major NTs implicated; serotonin, norepinephrine,
GABA
GABA
Role most strongly supported by the undisputed
efficacy of benzodiazepines, which enhance the
activity of GABA at the GABA type A receptor, in the
treatment of some types of anxiety disorders
Norepinephrine
Affected patients may have a poorly regulated
noradrenergic system with occasional bursts of
activity
11. Increased noradrenergic function -chronic symptoms
experienced by patients, such as panic attacks, insomnia,
startle, and autonomic hyperarousal
Serotonin
Different types of acute stress result in increased 5-
hydroxytryptamine (5-HT) turnover in the prefrontal
cortex, nucleus accumbens, amygdala, and lateral
hypothalamus
The effectiveness of buspirone, a 5-HT1A receptor agonist,
in the treatment of anxiety disorders
Clinical studies of 5-HT function in anxiety disorders have
had mixed results
12. IV. NEUROANATOMICAL
Locus coereleus and raphe nuclei project to limbic system and cerebral cortex.
Limbic System
Receives noradrenergic and serotonergic innervation and also contains a high
concentration of GABA receptors.
Ablation and stimulation studies in nonhuman primates have implicated the
limbic system in the generation of anxiety and fear responses.
Increased activity in the septohippocampal pathway may lead to anxiety
The cingulate gyrus has been implicated in the pathophysiology of OCD
Cerebral Cortex
The frontal cerebral cortex is connected with the parahippocampal region, the
cingulate gyrus, and the hypothalamus and may be involved in the production
of anxiety disorders
13. PANIC DISORDER
Panic disorder is recurrent unexpected panic attacks with or without agoraphobia
Panic attack is discrete period of intense fear or discomfort, in which four (or more) of
the following symptoms developed abruptly and reached a peak within 10 minutes:
STUDENTS Fear the 3Cs
1. Sweating
2. Trembling or shaking
3. Unsteadiness (dizziness), lightheaded
4. Derealization or depersonalization
5. Elevated heart rate (palpitations)
6. Nausea or abdominal distress
7. Tingling or numbness- paresthesia
8. Shortness of breath or smothering
9. Fear of dying
10. Fear of losing control or going
crazy
11. Chest pain or discomfort
12. Choking
13. Chills or hot flushes
14. Epidemiology
Lifetime prevalence is 1-4%
Women are 2-3times more likely to have panic
disorder
The only social factor is a recent history of
divorce or separation.
Most commonly develops in young adulthood the
mean age of presentation is about 25yrs though
can start at any age
It is associated with a lot of cormobidity;91%
have at least one other psychiatric disorder.
15. ETIOLOGY
1. Biological factors- major neurotransmitter systems
involved and also the importance of dysregulated CNS
2. Pain inducing substances
3. Genetic factors
4. Psychosocial factors
Psychoanalytic theory
Cognitive-behavioral theory
5. Brain imaging has shown panic attacks are associated with
cerebral vasoconstriction, which may result in CNS
symptoms, such as dizziness, and in peripheral nervous
system symptoms
16. CLINICAL FEATURES
1st attack often spontaneous although may follow excitement, physical
exertion, sexual activity or emotional trauma.
Preceding activities: use of caffeine, alcohol, nicotine, unusual sleeping or
eating habits
Begins with 10 minute period of rapidly increasing symptoms lasting 20-30
minutes rarely more than 1 hour
Physical symptoms include tachycardia, palpitations, dyspnea, sweating
MSE: impaired memory, stammering, depression, depersonalization,
rumination
Anticipatory fear between attacks
Somatic concerns of death from cardiorespiratory problems during attack
Syncopal episodes in 20%
Others: other phobias, marital discord, financial difficulties, alcohol and
substance use
17. DSM-IV-TR Diagnostic Criteria for Panic Disorder without Agoraphobia
A)Both (1) and (2):
1) recurrent unexpected panic attacks
2)at least one of the attacks has been followed by 1 month (or more) of one
(or more) of the following:
Persistent concern about having additional attacks
Worry about the implications of the attack or its consequences (e.g., losing
control, having a heart attack, or going crazy)
A significant change in behavior related to the attacks
B) Absence of agoraphobia
C) The panic attacks are not due to the direct physiological effects of a substance
(e.g., a drug of abuse, a medication) or a general medical condition (e.g.,
hyperthyroidism).
D) The panic attacks are not better accounted for by another mental disorder,
such as social phobia, specific phobia , OCD, PTSD, or separation anxiety disorder
18. DIFFERENTIAL DIAGNOSIS
• Medical disorders
• Specific and social phobias
• Mental disorders like GAD
• Agoraphobia without panic disorder
19. TREATMENT
A. Pharmacotherapy
• Benzodiazepines (alprazolam) and antidepressants
(paroxetine) are used
Experience is showing superiority of SSRIs and
clomipramine over the benzodiazepines and other
antidepressants
Treatment should generally continue for 8 to 12 months.
Panic disorder is a chronic condition and studies have
reported that 30 to 90% of patients who have had
successful treatment have a relapse when their medication
is discontinued
B. Cognitive and behavioral therapies
20. PROGNOSIS
30-40% of patients are symptom free on long term
follow up
50% have very mild symptoms and 10-20% have
significant symptoms
There is increased risk of suicide
Alcohol and substance dependency may occur in 20-40%
of patients while 40-80% may have depression
Patients with good premorbid functioning and symptoms
of brief duration tend to have good prognoses
21. AGORAPHOBIA
Phobia refers to marked and persistent fear that is
excessive or unreasonable cued by the presence or
anticipation of a specific object or situation
Agoraphobia- fear of or anxiety regarding places or
situations from which escape might be difficult
Interferes with a person's ability to function in work
and social situations outside the home-most disabling
22. EPIDEMIOLOGY
Prevalence varies between 2-6%
Can occur with or without panic disorder
The onset of agoraphobia mostly follows a
traumatic event.
84% of those with agoraphobia have at least
one other psychiatric condition
23. DSM-IV-TR Criteria for diagnosis of agoraphobia
A. Anxiety about being in places or situations from which escape
might be difficult (or embarrassing) or in which help may not be
available in the event of having an unexpected or situationally
predisposed panic attack or panic-like symptoms.
B. The situations are avoided (e.g., travel is restricted) or else are
endured with marked distress or with anxiety about having a
panic attack or panic-like symptoms, or require the presence of a
companion.
C. The anxiety or phobic avoidance is not better accounted for by
another mental disorder, such as social phobia, specific phobia,
OCD, PTSD, or separation anxiety
24. CLINICAL FEATURES
• Rigidly avoiding situations in which it would
be difficult to obtain help.
• Prefer to be accompanied by friend or family
member in busy streets, crowded stores,
closed in spaces or closed in vehicles.
• Severely affected patients may refuse to
leave the house
25. OBSESSIVE-COMPULSIVE DISORDER
An obsession is a recurrent and intrusive
thought, feeling, idea, or sensation while a
compulsion is a repetitive, conscious,
standardized, recurrent behavior that a person
feels driven to perform in response to an
obsession e.g. counting, checking, or avoiding.
A patient with OCD may have an obsession, a
compulsion, or both.
26.
27. EPIDEMIOLOGY
Life time prevalence of 2-3% ,
Affects both men and women equally (adults) but affecting
boys more than girls (adolescents).
Mean age of onset is 20 years
Occurs more commonly in single people and whites
compared to married and black people.
Commonly affected by other mental disorders:
• Major depressive disorder 67%
• Social phobia 25%
• Others like specific phobia, generalized anxiety
• 20-30% have history of tics
29. CLINICAL FEATURES
Patients often take their complaints to physicians other than
psychiatrists like to dermatologist, pediatricians, obstetricians
Most patients(up to 75% ) have both obsessions and
compulsions
No matter how vivid and compelling the obsession or
compulsion, the person usually recognizes it as absurd and
irrational.
Feels a strong desire to resist them
Obsessive thoughts or ideas, images, ruminations, doubts,
convictions and compulsive rituals
30. OCD has four major symptom patterns though the symptom of
an individual patient may overlap or change with time.
1. Contamination
2. Pathological doubt
3. Intrusive thoughts
4. Symmetry
On MSE the patients may show symptoms of depressive
disorders(50%), character traits suggesting obsessive compulsive
personality disorder
Men especially have higher than average celibacy rates
Others: hoarding, trichotillomania, nail biting and masturbation
31. DSM-IV-TR Criteria for diagnosis of OCD
A. Either obsessions or compulsions:
Obsessions as defined by (1), (2), (3), and (4):
1. recurrent and persistent thoughts, impulses, or images that are experienced, at some time during
the disturbance, as intrusive and inappropriate and that cause marked anxiety or distress
2. the thoughts, impulses, or images are not simply excessive worries about real-life problems
3. the person attempts to ignore or suppress such thoughts, impulses, or images, or to neutralize
them with some other thought or action
4. the person recognizes that the obsessional thoughts, impulses, or images are a product of his or
her own mind (not imposed from without as in thought insertion)
Compulsions as defined by (1) and (2):
1. repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts (e.g., praying, counting,
repeating words silently) that the person feels driven to perform in response to an obsession, or
according to rules that must be applied rigidly
2. the behaviors or mental acts are aimed at preventing or reducing distress or preventing some
dreaded event or situation; however, these behaviors or mental acts either are not connected in a
realistic way with what they are designed to neutralize or prevent or are clearly excessive
32. B. At some point during the course of the disorder, the person has recognized that
the obsessions or compulsions are excessive or unreasonable.
Note: This does not apply to children.
C. The obsessions or compulsions cause marked distress, are time-consuming
(take more than 1 hour a day), or significantly interfere with the person's normal
routine, occupational (or academic) functioning, or usual social activities or
relationships.
D. If another Axis I disorder is present, the content of the obsessions or
compulsions is not restricted to it (e.g., preoccupation with food in the presence
of an eating disorder;
E. The disturbance is not due to the direct physiological effects of a substance
(e.g., a drug of abuse, a medication) or a general medical condition.
• Specify if: With poor insight: if, for most of the time during the current
episode, the person does not recognize that the obsessions and compulsions
are excessive or unreasonable
33. DIFFERENTIAL DIAGNOSIS
• Medical conditions such as Sydenham's
chorea and Huntington's disease that affect
primarily the basal ganglia
• Tourette's Disorder
• Other Psychiatric Conditions like obsessive
compulsive personality disorder, depression,
psychotic episode
34. COURSE AND PROGNOSIS
• 20-30 % of patients have significant
improvement in their symptoms
• 40-50% have moderate improvement.
• The remaining 20-40% of patients either
remain ill or their symptoms worsen.
• One third of patients with OCD have major
depressive disorder
• Suicide is a risk for all patients with OCD.
35. Indications of Poor Prognosis
• Yielding to compulsions
• Childhood onset
• Bizarre compulsions,
• The need for hospitalization,
• A coexisting major depressive
disorder,
• Delusional beliefs,
• The presence of overvalued ideas
(i.E., Some acceptance of
obsessions and compulsions),
• Presence of a personality disorder
(especially schizotypal personality
disorder)
Indications of a Good Prognosis
• Good social and occupational
adjustment,
• The presence of a
precipitating event
• Episodic nature of the
symptoms.
36. Treatment
Pharmacotherapy
Start treatment with an SSRI or clomipramine and
then move to other pharmacological strategies if the
SSRIs drugs are not effective
Initial effects are generally seen after 4 to 6 weeks of
treatment
Behavior Therapy
Desensitization, thought stopping, flooding,
implosion therapy, and aversive conditioning
Psychotherapy
37. Posttraumatic Stress Disorder and Acute
Stress Disorder
• Posttraumatic stress disorder (PTSD) is a condition
marked by the development of symptoms after
exposure to traumatic life events with the symptoms
lasting more than a month significantly affecting daily
functioning
• Acute stress disorder occurs earlier than PTSD (within 4
weeks of the event) and remits within 2 days to 4 weeks
• The stressors are sufficiently overwhelming to affect
almost anyone and can arise from experiences in war,
torture, natural catastrophes, assault, rape, and
serious accidents.
38. • Persons re-experience the traumatic event in their
dreams and their daily thoughts;
• They are determined to evade anything that would bring
the event to mind and they undergo a numbing of
responsiveness along with a state of hyperarousal.
• Other symptoms are depression, anxiety, and cognitive
difficulties, such as poor concentration
• The term PTSD was introduced in the 1980s following
the psychiatric morbidity associated with Vietnam War
veterans
• Previously known as irritable heart, shell shock, combat
neurosis or operational fatigue
39. EPIDEMIOLOGY
Lifetime prevalence: 10 to 12% in women, 5 to 6% in men
and 5 to 75% in high-risk groups
Onset at any age but it is most prevalent in young adults,
as they tend be more exposed to precipitating situations
Comorbidity rates are high with about two thirds having
at least two other disorders which make persons more
vulnerable to developing PTSD
Common comorbid conditions: depressive disorders,
substance-related disorders, other anxiety disorders, and
bipolar disorders
40. ETIOLOGY
Stressor
Risk factors
Psychodynamic
Factors
Cognitive-Behavioral
Factors
Biological Factors
• Presence of childhood trauma
• Borderline, paranoid, dependent, or
antisocial personality disorder traits
• Inadequate family or peer support system
• Being female
• Genetic vulnerability to psychiatric illness
• Recent stressful life changes
• Perception of an external locus of control
(natural) rather than an internal one (human)
• Recent excessive alcohol intake
41. DSM-IV-TR Diagnostic Criteria for Posttraumatic Stress Disorder
A)The person has been exposed to a traumatic event in which both of the following were
present:
– the person experienced, witnessed, or was confronted with an event or events that involved
actual or threatened death or serious injury, or a threat to the physical integrity of self or others
– the person's response involved intense fear, helplessness, or horror. a2
B)The traumatic event is persistently re-experienced in one (or more) of the following ways:
– recurrent and intrusive distressing recollections of the event, including images, thoughts, or
perceptions.
– recurrent distressing dreams of the event
– acting or feeling as if the traumatic event were recurring (includes a sense of reliving the
experience, illusions, hallucinations, and dissociative flashback episodes, including those that
occur on awakening or when intoxicated).
– intense psychological distress at exposure to internal or external cues that symbolize or
resemble an aspect of the traumatic event
– physiological reactivity on exposure to internal or external cues that symbolize or resemble an
aspect of the traumatic event
42. C) Persistent avoidance of stimuli associated with the trauma and numbing of general
responsiveness (not present before the trauma), as indicated by three (or more) of the
following:
– efforts to avoid thoughts, feelings, or conversations associated with the trauma
– efforts to avoid activities, places, or people that arouse recollections of the trauma
– inability to recall an important aspect of the trauma
– markedly diminished interest or participation in significant activities
– feeling of detachment or estrangement from others
– restricted range of affect (e.g., unable to have loving feelings)
– sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life
span)
D) Persistent symptoms of increased arousal (not present before the trauma), as indicated by
two (or more) of the following:
– difficulty falling or staying asleep
– irritability or outbursts of anger
– difficulty concentrating
– hypervigilance
– exaggerated startle response
43. E) Duration of the disturbance (symptoms in Criteria B, C,
and D) is more than 1 month.
F) The disturbance causes clinically significant distress or
impairment in social, occupational, or other important
areas of functioning.
Specify if:
Acute: if duration of symptoms is less than 3 months
Chronic: if duration of symptoms is 3 months or more
Specify if:
With delayed onset: if onset of symptoms is at least 6
months after the stressor
44. DSM-IV-TR Diagnostic Criteria for Acute Stress Disorder
A. The person has been exposed to a traumatic event in which both of the following were
present:
the person experienced, witnessed, or was confronted with an event or events that
involved actual or threatened death or serious injury, or a threat to the physical
integrity of self or others
the person's response involved intense fear, helplessness, or horror
B. Either while experiencing or after experiencing the distressing event, the individual has
three (or more) of the following dissociative symptoms:
a subjective sense of numbing, detachment, or absence of emotional responsiveness
a reduction in awareness of his or her surroundings
derealization
depersonalization
dissociative amnesia (i.e., inability to recall an important aspect of the trauma)
45. C. The traumatic event is persistently re-experienced in at least one of the following
ways: recurrent images, thoughts, dreams, illusions, flashback episodes, or a sense
of reliving the experience; or distress on exposure to reminders of the traumatic
event.
D. Marked avoidance of stimuli that arouse recollections of the trauma (e.g., thoughts,
feelings, conversations, activities, places, people).
E. Marked symptoms of anxiety or increased arousal (e.g., difficulty sleeping,).
F. The disturbance causes clinically significant distress or impairment in social,
occupational, or other important areas of functioning or impairs the individual's
ability to pursue some necessary task, such as obtaining necessary assistance or
mobilizing personal resources by telling family members about the traumatic
experience.
G. The disturbance lasts for a minimum of 2 days and a maximum of 4 weeks and occurs
within 4 weeks of the traumatic event.
H. The disturbance is not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition, is not better accounted
for by brief psychotic disorder, and is not merely an exacerbation of a preexisting Axis
I or Axis II disorder.
46. DIFFERENTIAL DIAGNOSIS
• Other medical conditions
• Head injury, organic considerations that can both cause
and exacerbate the symptoms like epilepsy, alcohol-use
disorders, and other substance-related disorders
• Panic disorder and generalized anxiety disorder
• Major depression is also a frequent concomitant of
PTSD.
• Borderline personality disorder, dissociative disorders,
and factitious disorders
47. TREATMENT
• Pharmacotherapy
Selective serotonin reuptake inhibitors (SSRIs),
such as sertraline (Zoloft) and paroxetine
(Paxil), are considered first-line treatments
• Psychotherapy
behavior therapy, cognitive therapy, and
hypnosis
48. COURSE AND PROGNOSIS
• Untreated, about 30% of patients recover completely, 40%
continue to have mild symptoms, 20% continue to have
moderate symptoms, and 10% remain unchanged or
become worse
Good Prognostic Factors
• rapid onset of the symptoms,
• short duration of the symptoms (less than 6 months),
• good premorbid functioning,
• strong social supports
• absence of other psychiatric, medical or substance-related
disorders.
49. GENERALIZED ANXIETY DISORDER
GAD: excessive anxiety and worry about several
events or activities for most days during at least a
6-month period.
The worry is difficult to control and is associated
with somatic symptoms, such as muscle tension,
irritability, difficulty sleeping, and restlessness
50. EPIDEMIOLOGY
Lifetime prevalence close to 5 percent some studies
suggesting 8%
F:M 2:1, Inpatient treatment 1:1
Onset in late adolescence or early adulthood, although
cases are commonly seen in older adults
50 to 90 percent of patients with generalized anxiety
disorder have another mental disorder usually social
phobia, specific phobia, panic disorder or a depressive
disorder
51. DSM-IV-TR Diagnostic Criteria for Generalized Anxiety Disorder
A. Excessive anxiety and worry (apprehensive expectation), occurring
more days than not for at least 6 months, about a number of events
or activities (such as work or school performance).
B. The person finds it difficult to control the worry.
C. The anxiety and worry are associated with three (or more) of the
following six symptoms (with at least some symptoms present for
more days than not for the past 6 months).
i. restlessness or feeling keyed up or on edge
ii. being easily fatigued
iii. difficulty concentrating or mind going blank
iv. irritability
v. muscle tension
vi. sleep disturbance (difficulty falling or staying asleep, or restless
unsatisfying sleep)
52. D. The focus of the anxiety and worry is not confined to features of an Axis I disorder,
e.g., the anxiety or worry is not about having a panic attack (as in panic disorder),
being embarrassed in public (as in social phobia), being contaminated (as in
obsessive-compulsive disorder), being away from home or close relatives (as in
separation anxiety disorder), gaining weight (as in anorexia nervosa), having multiple
physical complaints (as in somatization disorder), or having a serious illness (as in
hypochondriasis), and the anxiety and worry do not occur exclusively during
posttraumatic stress disorder.
E. The anxiety, worry, or physical symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of functioning.
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism)
and does not occur exclusively during a mood disorder, a psychotic disorder, or a
pervasive developmental disorder
53. CLINICAL FEATURES
Sustained and excessive anxiety and worry accompanied
by a number of physiological symptoms.
The anxiety is excessive and interferes with other
aspects of a person's life occurring more days than not
for at least 6 months.
Motor tension is most commonly manifested as
shakiness, restlessness, and headaches
Autonomic hyperactivity is commonly manifested by
shortness of breath, excessive sweating, palpitations,
and various gastrointestinal symptoms
Cognitive vigilance is evidenced by irritability and the
ease with which patients are startled
54. DIFFERENTIAL DIAGNOSIS
Medical conditions
• Neurological,
• endocrinological,
• metabolic, and
• medication-related disorders similar to those considered in the
differential diagnosis of panic disorder
Other anxiety conditions
• panic disorder,
• phobias,
• obsessive-compulsive disorder (OCD)
• posttraumatic stress disorder (PTSD).
55. TREATMENT
The most effective treatment of generalized anxiety disorder is probably
one that combines psychotherapeutic, pharmacotherapeutic and
supportive approaches
Psychotherapy
cognitive-behavioral, supportive, and insight oriented
Pharmacotherapy
Treatment is almost lifelong in many cases due to the observed
incidences 25%, of relapse on discontinuation of medication within the
year and 60-80% over the course of the next year
• benzodiazepines,
• SSRIs(fluoxetine),
• buspirone (BuSpar)
• venlafaxine (Effexor)
56. COURSE AND PROGNOSIS
• Clinical course and prognosis is difficult to
predict
• Most patients have early onset seeking
treatment later on (only 1/3)
• Generally a lifelong condition with fluctuating
course
57. SPECIFIC PHOBIA AND SOCIAL PHOBIA
o Phobia refers to an excessive fear of a specific object,
circumstance, or situation.
o A specific phobia is a strong, persisting fear of an object or
situation(situation type, animal type, natural environment type
or injury and blood)
o Social phobia is a strong, persisting fear of social situations in
which a person is exposed to unfamiliar people or possible
scrutiny by others .
o The individual fears that he will act in a way that will be
humiliating or embarrassment can occur.
o The diagnosis of both specific and social phobias requires the
development of intense anxiety, even to the point of panic,
when exposed to the feared object or situation
58. EPIDEMIOLOGY
o As high as 25 percent of the population affected by phobias.
o Complications including other anxiety disorders, major depressive
disorder, and substance-related disorders, especially alcohol use
disorders.
Specific phobia
o lifetime prevalence of specific phobia is about 11 percent
o most common mental disorder among women and the second most
common among men, second only to substance-related disorders
Social phobia
o Lifetime prevalence of social of 3 to 13 percent
o Females are affected more often than males
o Peak age of onset is in the teens although can start as early as five
years
60. DSM-IV-TR Diagnostic Criteria for Specific Phobia
A. Marked and persistent fear that is excessive or unreasonable, cued
by the presence or anticipation of a specific object or situation (e.g.,
flying, heights, animals, receiving an injection, seeing blood).
B. Exposure to the phobic stimulus almost invariably provokes an
immediate anxiety response, which may take the form of a
situationally bound or situationally predisposed panic attack.
Note: In children, the anxiety may be expressed by crying,
tantrums, freezing, or clinging.
C. The person recognizes that the fear is excessive or unreasonable.
D. The phobic situation(s) is avoided or else is endured with intense
anxiety or distress.
61. E. The avoidance, anxious anticipation, or distress in the feared situation(s)
interferes significantly with the person's normal routine, occupational functioning,
or social activities or relationships, or there is marked distress about having the
phobia.
F. In individuals under age 18 years, the duration is at least 6 months.
G. The anxiety, panic attacks, or phobic avoidance associated with the specific object
or situation are not better accounted for by another mental disorder, such as
obsessive-compulsive disorder (e.g., fear of dirt in someone with an obsession
about contamination), posttraumatic stress disorder (e.g., avoidance of stimuli
associated with a severe stressor), separation anxiety disorder (e.g., avoidance of
school), social phobia (e.g., avoidance of social situations because of fear of
embarrassment), panic disorder with agoraphobia, or agoraphobia without history
of panic disorder.
• Specify type:
Animal type
Natural environment type (e.g., heights, storms, water)
Blood-injection-injury type
Situational type (e.g., airplanes, elevators, enclosed places)
Other type (e.g., fear of choking, vomiting, or contracting an illness; in children,
fear of loud sounds or costumed characters)
62. Phobias
Acrophobia fear of heights
Agoraphobia fear of open places
Ailurophobia fear of cats
Hydrophobia fear of water
Claustrophobia fear of closed spaces
Cynophobia fear of dogs
Mysophobia fear of dirt and germs
Pyrophobia fear of fire
Xenophobia fear of strangers
Zoophobia fear of animals
63. DSM-IV-TR Diagnostic Criteria for Social Phobia
A. A marked and persistent fear of one or more social or performance
situations in which the person is exposed to unfamiliar people or to
possible scrutiny by others. The individual fears that he or she will act in
a way (or show anxiety symptoms) that will be humiliating or
embarrassing.
Note: In children, there must be evidence of the capacity for age-
appropriate social relationships with familiar people and the anxiety
must occur in peer settings, not just in interactions with adults.
B. Exposure to the feared social situation almost invariably provokes
anxiety, which may take the form of a situationally bound or
situationally predisposed panic attack.
C. The person recognizes that the fear is excessive or unreasonable.
Note: In children, this feature may be absent.
D. The feared social or performance situations are avoided or else are
endured with intense anxiety or distress.
64. E. The avoidance, anxious anticipation, or distress in the feared social or
performance situation(s) interferes significantly with the person's
normal routine, occupational (academic) functioning, or social activities
or relationships, or there is marked distress about having the phobia.
F. In individuals under age 18 years, the duration is at least 6 months.
G. The fear or avoidance is not due to the direct physiological effects of a
substance or a general medical condition and is not better accounted for
by another mental disorder (e.g., panic disorder with or without
agoraphobia, separation anxiety disorder, body dysmorphic disorder, a
pervasive developmental disorder, or schizoid personality disorder).
H. If a general medical condition or another mental disorder is present, the
fear in Criterion A is unrelated to it (e.g., the fear is not of stuttering,
trembling in Parkinson's disease, or exhibiting abnormal eating behavior in
anorexia nervosa or bulimia nervosa).
• Specify if:
Generalized: if the fears include most social situations
65. Differential diagnosis
o Appropriate fear and normal shyness
o Nonpsychiatric medical conditions that can result in the
development of a phobia include the use of substances
(hallucinogens and sympathomimetic), central nervous system
tumors and cerebrovascular diseases.
o Schizophrenia
o Panic disorder and agoraphobia
o Avoidant personality disorder
Social phobia- major depressive disorder and schizoid personality
disorder
Specific phobia- hypochondriasis, OCD and paranoid personality
disorder
66. TREATMENT
Behavior Therapy
• Insight-Oriented Psychotherapy
Specific Phobia
- Exposure therapy
- adrenergic receptor antagonists esp if associated with panic
symptoms
- Benzodiazepines
Social phobia
- Both psychotherapy and pharmacotherapy
- Effective drugs include (1) SSRIs, (2) the benzodiazepines, (3)
venlafaxine (Effexor), and (4) buspirone (BuSpar).
67. OTHER ANXIETY DISORDERS
1. Anxiety Disorder due to a General Medical
Condition
2. Substance-Induced Anxiety Disorder
3. Anxiety Disorder not Otherwise Specified
4. Mixed Anxiety-Depressive Disorder
Editor's Notes
Anxiety is often characterized by diffuse, unpleasant, vague sense of apprehension, often accompanied by autonomic symptoms like headache, perspirations, palpitation etc
Others..
High levels of neuropeptide Y are associated with better performance
Corticotrophin releasing hormone levels are increased by stress in the hypothalamus leading to activation of Hypothalamic-Pituitary-Adrenal axis hence increased cortisol levels. HPA axis dysfunction has been demonstrated in PTSD
Galanin- Is a peptide that in humans that demonstrated to be involved in a number of physiological and behavioral functions, including learning and memory, pain control, food intake, neuroendocrine control, cardiovascular regulation and most recently, anxiety.
Studies in rats have shown that galanin administered centrally modulates anxiety-related behaviors.
ANS; anxiety patients have increased sympathetic tone, adapt slowly to repeated stimuli and respond excessively to moderate stimuli
Derealization (feelings of unreality)
Depersonalization (being detached from oneself)
social phobia (e.g., occurring on exposure to feared social situations),
specific phobia (e.g., on exposure to a specific phobic situation),
obsessive-compulsive disorder (e.g., on exposure to dirt in someone with an obsession about contamination),
posttraumatic stress disorder (e.g., in response to stimuli associated with a severe stressor), or
separation anxiety disorder (e.g., in response to being away from home or close relatives).
Agoraphobic fears typically involve characteristic clusters of situations that include being outside the home alone; being in a crowd or standing in a line; being on a bridge; and traveling in a bus, train, or automobile.
Note: Consider the diagnosis of specific phobia if the avoidance is limited to one or only a few specific situations, or social phobia if the avoidance is limited to social situations.
hair pulling in the presence of trichotillomania; concern with appearance in the presence of body dysmorphic disorder
a2. Note: In children, this may be expressed instead by disorganized or agitated behavior
B1. Note: In young children, repetitive play may occur in which themes or aspects of the trauma are expressed.
b2. Note: In children, there may be frightening dreams without recognizable content.
B3. Note: In young children, trauma-specific reenactment may occur